We are live on ! Find out more
GF

Gates Foundation Portfolio holdings

AUM $43.5M
1-Year Est. Return 14.19%
This Fund
S&P 500
This Quarter Est. Return
+10.26%
1 Year Est. Return
+14.19%
3 Year Est. Return
-58.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$130M
AUM Growth
+$3.28M
Cap. Flow
-$965K
Cap. Flow %
-0.74%
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
2
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CVAC
CureVac
CVAC
+$619K
2
ZY
Zymergen Inc. Common Stock
ZY
+$200K
3
BCEL
Atreca, Inc. Class A Common Stock
BCEL
+$146K

Sector Composition

Rank Sector Weight
1 Healthcare 99.64%
2 Materials 0.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VIR icon
1
Vir Biotechnology
VIR
$1.46B
$39.5M 30.41%
1,559,142
– –
IMCR icon
2
Immunocore
IMCR
$1.79B
$32.9M 25.37%
576,923
– –
BNTX icon
3
BioNTech
BNTX
$22.6B
$22.3M 17.21%
148,674
– –
LMDX
4
DELISTED
LumiraDx Limited Common Shares
LMDX
$12.9M 9.91%
14,285,714
– –
CVAC
5
DELISTED
CureVac
CVAC
$9.8M 7.55%
1,625,943
-83,838
-5% -$619K
EXAI
6
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$8.48M 6.53%
1,590,909
– –
BFLY icon
7
Butterfly Network
BFLY
$1.71B
$2.49M 1.92%
1,011,003
– –
BCEL
8
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$965K 0.74%
1,206,097
-114,783
-9% -$146K
AMRS
9
DELISTED
Amyris Inc.
AMRS
$465K 0.36%
292,398
– –
ZY
10
DELISTED
Zymergen Inc. Common Stock
ZY
– –
-59,970
Closed -$200K

Similar funds

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
IV
Industry Ventures San Francisco, California $43.2M AUM 36.57% 1-Year Est. Return
RCM
Riverwood Capital Management Menlo Park, California $43.2M AUM 24% 1-Year Est. Return
EPWM
Essex Private Wealth Management Topsfield, Massachusetts $42.5M AUM 29.61% 1-Year Est. Return
SCMC
Serent Capital Management Company San Francisco, California $44.9M AUM 20.57% 1-Year Est. Return
GF
Genesis Fortune Grand Cayman, Cayman Islands $41.8M AUM 76.19% 1-Year Est. Return
AS
AM Squared Hong Kong $45.2M AUM 4.27% 1-Year Est. Return
BCP
Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return

Gates Foundation's Q4 2022 Portfolio in Review

As of Q4 2022, Gates Foundation held 10 positions worth $130M, up 2.6% from $127M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Gates Foundation's Q4 2022 filing shows 2 reduced and 1 closed positions. The largest sale was CureVac, an estimated $619K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier, followed by Materials.

  • Gates Foundation's biggest Q4 2022 reduction was CureVac, cutting an estimated $619K.
  • Gates Foundation fully exited Zymergen Inc. Common Stock in Q4 2022, selling an estimated $200K.
  • Gates Foundation's ten largest holdings make up 100% of its $130M portfolio in Q4 2022.
  • Gates Foundation opened 0 new positions and closed 1 in Q4 2022.
  • Gates Foundation's portfolio value rose 2.6% quarter-over-quarter to $130M.

Based on Gates Foundation's 13F filing for Q4 2022, filed 14 Feb 2023.